February 27, 2017 / 7:46 AM / 5 months ago

BRIEF-Dechra Pharmaceuticals says half-year revenue up at 172.6 mln stg

1 Min Read

Feb 27 (Reuters) - Dechra Pharmaceuticals Plc:

* Half-Yearly financial report 2017

* Half-Yearly financial report 2017 for six months ended 31 december 2016

* Hy total group revenue of £172.6 million, a growth of 34.7 pct at constant exchange rate (cer) (55.9 pct at actual exchange rate (aer)).

* Hy core (excluding acquisitions) european pharmaceuticals (eu pharmaceuticals) segment revenue growth of 5.9 pct at cer (20.0 pct at aer).

* Hy underlying operating profit increased by 28.6 pct at cer (47.1 pct at aer).

* Net cash inflow from underlying operating activities of £43.9 million with a cash conversion of 124.0 pct. Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below